南京医药：累计回购公司股份1629.9951万股

Core Viewpoint - Nanjing Pharmaceutical announced the completion of a share buyback program, having repurchased a total of 16,299,951 shares as of July 31, 2025 [2] Summary by Relevant Sections - Company Actions - The company has executed a share buyback through centralized bidding, accumulating a total of 16,299,951 shares [2] - Timeline - The share buyback program is set to conclude on July 31, 2025 [2]